Literature DB >> 1540898

Molecular marker test standardization.

J A Koepke1.   

Abstract

A review of the status of standardization of laboratory tests of particular interest to oncologists is presented. Currently, relatively few of these tests are standardized; as a result, interlaboratory and interinstitutional comparison of data is problematic. In 1992, additional interlaboratory studies of common tumor markers will be initiated by the College of American Pathologists. The National Committee for Clinical Laboratory Standards also has begun to develop standard methods and guidelines for these important tests.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540898     DOI: 10.1002/1097-0142(19920315)69:6+<1578::aid-cncr2820691312>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Elevation of serum carcinoembryonic antigen level in a patient with hypothyroidism after radiation therapy for cervical esophageal cancer.

Authors:  Gen Kawaguchi; Eisuke Abe; Ryuta Sasamoto; Keisuke Sasai
Journal:  Int J Clin Oncol       Date:  2010-01-22       Impact factor: 3.402

2.  Signaling pathways activation profiles make better markers of cancer than expression of individual genes.

Authors:  Nikolay M Borisov; Nadezhda V Terekhanova; Alexander M Aliper; Larisa S Venkova; Philip Yu Smirnov; Sergey Roumiantsev; Mikhail B Korzinkin; Alex A Zhavoronkov; Anton A Buzdin
Journal:  Oncotarget       Date:  2014-10-30

3.  National survey on internal quality control for tumour markers in clinical laboratories in China.

Authors:  Wei Wang; Kun Zhong; Shuai Yuan; Falin He; Yuxuan Du; Zhehui Hu; Zhiguo Wang
Journal:  Biochem Med (Zagreb)       Date:  2018-04-15       Impact factor: 2.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.